Current Oncology: Canadian Costing Supplement is now Available

In the recent Current Oncology: Canadian Costing Supplement many ARCC members research has been highlighted. For these researchers we would like to send out a big congratulations! This supplement that has been co-edited by Nicole Mittmann (Cancer Care Ontario, Toronto, Ontario), and Claire de Oliveria (Centre for Addiction and Mental Health, Toronto, Ontario).

The outstanding contributions of ARCC members, associates, and investigators to this special supplement include:


Original Canadian cancer costing research for cancer control sustainability, quality, and value PDF HTML
H. Bryant S5
Importance of cost estimates and cost studies PDF HTML
N. Mittmann, C. de Oliveira S6

Original Article(s)

Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada PDF HTML
P.A. Tang, A.E. Hay, C.J. O’Callaghan, N. Mittmann, C.R. Chambers, J.L. Pater, N.B. Leighl S7-S13
Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis PDF HTML
I. Cromwell, Z. Ferreira, L. Smith, K. van der Hoek, G. Ogilvie, A. Coldman, S.J. Peacock S14-S22
Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation PDF HTML
N.J. Look Hong, G.M. Clarke, M.J. Yaffe, C.M.B. Holloway S23-S31
Population-based trends in systemic therapy use and cost for cancer patients in the last year of life PDF HTML
R.E. Pataky, W.Y. Cheung, C. de Oliveira, K.E. Bremner, K.K.W. Chan, J.S. Hoch, M.D. Krahn, S.J. Peacock S32-S41
Temporal association between home nursing and hospital costs at end of life in three provinces PDF HTML
H. Seow, R. Pataky, B. Lawson, E.M. O’Leary, R. Sutradhar, K. Fassbender, K. McGrail, L. Barbera, F. Burge, S.J. Peacock, J.S. S Hoch S42-S51
Cost implications of unwarranted imaging for distant metastasis in women with early-stage breast cancer in Ontario PDF HTML
K. Thavorn, Z. Wang, D. Fergusson, S. van Katwyk, A. Arnaout, M. Clemons S52-S55
Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada PDF HTML
C. Popadiuk, C.L. Gauvreau, M. Bhavsar, C. Nadeau, K. Asakawa, W.M. Flanagam, M.C. Wolfson, A.J. Coldman, S. Memon, N. Fitzgerald, J. Lacombe, A.B. Miller S56-S63
Cost trajectories for cancer patients PDF HTML
W.P Wodchis, E. Arthurs, A.I. Khan, S. Gandhi, M. MacKinnon, J. Sussman S64-S75


0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply